Indeed, the pharmacological inhibition of p38 and JNK by rosuvastatin inhibited the activation of microglia and astrocytes and reduced stroke injury (Piao et al., 2003) while also decreasing the expression of these inflammatory cytokines. The gene discussed is MAPK8; the disease is Stroke.